The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
EML4-ALK-gene rearrangement comparative analysis in circulating tumor cells and in tumor tissue of patients with lung adenocarcinoma.
Marius Ilie
No relevant relationships to disclose
Elodie Long
No relevant relationships to disclose
Catherine Butori
No relevant relationships to disclose
Veronique Hofman
No relevant relationships to disclose
Celine Coelle
No relevant relationships to disclose
Virginie Mauro
No relevant relationships to disclose
Katia Zahaf
No relevant relationships to disclose
Charles Hugo Marquette
No relevant relationships to disclose
Jerome Mouroux
No relevant relationships to disclose
Patrizia Paterlini-Brechot
Employment or Leadership Position - Rarecells (U); Rarecells Holding (U)
Stock Ownership - Rarecells
Paul Hofman
No relevant relationships to disclose